Get started
666

SINEW PHARMA INC

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

6634 chart


Full chart

Key stats


Market capitalization
‪3.94 B‬TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.5TWD
Net income (FY)
‪−170.92 M‬TWD
Revenue (FY)
0.00TWD
Shares float
—
Beta (1Y)
−0.05

About SINEW PHARMA INC


Sector
Health Technology
Industry
Biotechnology
CEO
Kai Min Zhu
Website
sinewpharma.com
Headquarters
Taipei
Founded
2014
ISIN
TW0006634009
FIGI
BBG00H09BN90
Sinew Pharma, Inc. engages in the research and development of drugs related to liver disease treatment and pain treatment. It develops acetaminophen, drugs for non-alcoholic steatohepatitis, and acetaminophen poisoning antidotes. The company was founded by Kai Min Chu on June 18, 2014 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6634 is 55.0 TWD — it has decreased by −0.36% in the past 24 hours. Watch SINEW PHARMA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange SINEW PHARMA INC stocks are traded under the ticker 6634.
6634 stock has fallen by −1.08% compared to the previous week, the month change is a −11.00% fall, over the last year SINEW PHARMA INC has showed a −12.70% decrease.
6634 reached its all-time high on Jul 7, 2020 with the price of 170.9 TWD, and its all-time low was 12.6 TWD and was reached on Dec 14, 2018. View more price dynamics on 6634 chart.
See other stocks reaching their highest and lowest prices.
6634 stock is 3.56% volatile and has beta coefficient of −0.05. Track SINEW PHARMA INC stock price on the chart and check out the list of the most volatile stocks — is SINEW PHARMA INC there?
Today SINEW PHARMA INC has the market capitalization of ‪3.94 B‬, it has decreased by −0.54% over the last week.
Yes, you can track SINEW PHARMA INC financials in yearly and quarterly reports right on TradingView.
6634 net income for the last half-year is ‪−73.88 M‬ TWD, while the previous report showed ‪−104.60 M‬ TWD of net income which accounts for 29.38% change. Track more SINEW PHARMA INC financial stats to get the full picture.
No, 6634 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6634 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINEW PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINEW PHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINEW PHARMA INC stock shows the strong sell signal. See more of SINEW PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.